These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32226302)

  • 1. Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration.
    Xu J; Luo Y; Yuan C; Han L; Wu Q; Xu L; Gao Y; Sun Y; Ma S; Tang G; Li S; Sun W; Gong Y; Xie C
    Int J Biol Sci; 2020; 16(9):1563-1574. PubMed ID: 32226302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model.
    Ito H; Ando T; Seishima M
    Oncotarget; 2015 Dec; 6(39):41863-74. PubMed ID: 26496031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.
    Hanoteau A; Newton JM; Krupar R; Huang C; Liu HC; Gaspero A; Gartrell RD; Saenger YM; Hart TD; Santegoets SJ; Laoui D; Spanos C; Parikh F; Jayaraman P; Zhang B; Van der Burg SH; Van Ginderachter JA; Melief CJM; Sikora AG
    J Immunother Cancer; 2019 Jan; 7(1):10. PubMed ID: 30646957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
    Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
    Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
    Langle YV; Balarino NP; Belgorosky D; Cresta Morgado PD; Sandes EO; Marino L; Bilbao ER; Zambrano M; Lodillinsky C; Eiján AM
    Nitric Oxide; 2020 May; 98():50-59. PubMed ID: 32147582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8
    Cartwright ANR; Suo S; Badrinath S; Kumar S; Melms J; Luoma A; Bagati A; Saadatpour A; Izar B; Yuan GC; Wucherpfennig KW
    Cancer Immunol Res; 2021 Apr; 9(4):470-485. PubMed ID: 33514509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.
    Raber PL; Thevenot P; Sierra R; Wyczechowska D; Halle D; Ramirez ME; Ochoa AC; Fletcher M; Velasco C; Wilk A; Reiss K; Rodriguez PC
    Int J Cancer; 2014 Jun; 134(12):2853-64. PubMed ID: 24259296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
    Ager EI; Kozin SV; Kirkpatrick ND; Seano G; Kodack DP; Askoxylakis V; Huang Y; Goel S; Snuderl M; Muzikansky A; Finkelstein DM; Dransfield DT; Devy L; Boucher Y; Fukumura D; Jain RK
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25710962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide short-circuits interleukin-12-mediated tumor regression.
    Egilmez NK; Harden JL; Virtuoso LP; Schwendener RA; Kilinc MO
    Cancer Immunol Immunother; 2011 Jun; 60(6):839-45. PubMed ID: 21387108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
    Fahey JM; Girotti AW
    Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte-mediated macrophage apoptosis during IL-12 stimulation.
    Yim JY; Yang SJ; Yim JM; Song MY; Rho HW; Yim SK; Han YH; Jeon SY; Kim HS; Yhim HY; Lee NR; Song EK; Kwak JY; Sohn MH; Yim CY
    Cytokine; 2013 Oct; 64(1):62-70. PubMed ID: 23953854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.
    Sikora AG; Gelbard A; Davies MA; Sano D; Ekmekcioglu S; Kwon J; Hailemichael Y; Jayaraman P; Myers JN; Grimm EA; Overwijk WW
    Clin Cancer Res; 2010 Mar; 16(6):1834-44. PubMed ID: 20215556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark.
    Urdanibia I; Michelangeli F; Ruiz MC; Milano B; Taylor P
    J Ethnopharmacol; 2013 Dec; 150(3):1154-62. PubMed ID: 24212077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice.
    Ito H; Ando T; Ogiso H; Arioka Y; Seishima M
    Cancer Immunol Immunother; 2015 Apr; 64(4):429-36. PubMed ID: 25567751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice.
    Zhou R; He PL; Ren YX; Wang WH; Zhou RY; Wan H; Ono S; Fujiwara H; Zuo JP
    Cancer Sci; 2007 Jun; 98(6):882-9. PubMed ID: 17433038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
    Ohtsu N; Takaoka K; Segawa E; Hashitani S; Noguchi K; Kishimoto H; Urade M
    Oncol Rep; 2010 Jul; 24(1):31-6. PubMed ID: 20514441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant
    Deng W; Lira V; Hudson TE; Lemmens EE; Hanson WG; Flores R; Barajas G; Katibah GE; Desbien AL; Lauer P; Leong ML; Portnoy DA; Dubensky TW
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8179-8184. PubMed ID: 30038013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer.
    Feng PH; Lee KY; Chang YL; Chan YF; Kuo LW; Lin TY; Chung FT; Kuo CS; Yu CT; Lin SM; Wang CH; Chou CL; Huang CD; Kuo HP
    Am J Respir Crit Care Med; 2012 Nov; 186(10):1025-36. PubMed ID: 22955317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors.
    Lin L; Kane N; Kobayashi N; Kono EA; Yamashiro JM; Nickols NG; Reiter RE
    Clin Cancer Res; 2021 Mar; 27(5):1505-1515. PubMed ID: 33219015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.